Involvement of κ-opioid receptors and σ receptors in memory function demonstrated using an antisense strategy

Brain Research

Volumn 1030, Issue 2, 2004, Pages 247-255

  Hiramatsu, Masayuki ^a   Hoshino, Takashi ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Opioid receptor; Receptor; Antisense; Learning and memory; U 50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ACETIC ACID; ANTINOCICEPTIVE AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; KAPPA OPIATE RECEPTOR; PENTAZOCINE; SCOPOLAMINE; SIGMA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXON; MALE; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; WRITHING TEST;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANIMALS; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MEMORY DISORDERS; MEMORY, SHORT-TERM; MICE; NOCICEPTORS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RECEPTORS, OPIOID, KAPPA; RECEPTORS, SIGMA; SCOPOLAMINE;

EID: 9644268868     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.10.020     Document Type: Article

References (38)

1. R.T. Bartus, R.L. Dean, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
2. R.J. Beninger, B.A. Wirsching, K. Jhamands, and R.J. Boegman Animal studies of brain acetylcholine and memory Arch. Gerontol. Geriatr., Suppl. 1 1989 71 89
3. W.D. Bowen, S.B. Hellewell, and K.A. McGarry Evidence for a multi-site model of the rat brain sigma receptor Eur. J. Pharmacol. 163 1989 309 318
4. C.-C. Chien, and G.W. Pasternak Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid κ1 system Eur. J. Pharmacol. 250 1993 R7 R8
5. C.-C. Chien, and G.W. Pasternak Selective antagonism of opioid analgesia by a sigma system J. Pharmacol. Exp. Ther. 271 1994 1583 1590
6. J.T. Coyle, D.L. Price, and M.R. DeLong Alzheimer's disease: a disorder of cortical cholinergic innervation Science 219 1983 1184 1190
7. T.J. Haley, and W.G. McCormick Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse Br. J. Pharmacol. 12 1957 12 15
8. J.M. Hiller, Y. Itzhak, and E.J. Simon Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients Brain Res. 406 1987 17 23
9. M. Hiramatsu, and K. Inoue Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory Eur. J. Pharmacol. 395 2000 149 156
10. M. Hiramatsu, M. Sasaki, and T. Kameyama Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task Eur. J. Pharmacol. 282 1995 185 189
11. M. Hiramatsu, T. Hyodo, and T. Kameyama U-50,488H, a selective κ-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice Eur. J. Pharmacol. 315 1996 119 126
12. M. Hiramatsu, M. Sasaki, T. Nabeshima, and T. Kameyama Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice Pharmacol. Biochem. Behav. 56 1997 73 79
13. M. Hiramatsu, H. Murasawa, H. Mori, and T. Kameyama Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist Br. J. Pharmacol. 123 1998 920 926
14. M. Hiramatsu, H. Murasawa, T. Nabeshima, and T. Kameyama Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats J. Pharmacol. Exp. Ther. 284 1998 858 867
15. M. Hiramatsu, K. Inoue, and T. Kameyama Dynorphin A-(1-13) and (2-13) improve beta-amyloid peptide-induced amnesia in mice NeuroReport 11 2000 431 435
16. M. Hiramatsu, T. Hoshino, T. Kameyama, and T. Nabeshima Involvement of κ-opioid and σ receptors in short-term memory in mice Eur. J. Pharmacol. 453 2002 91 96
17. T. Hoshino, M. Hiramatsu, T. Kameyama, and T. Nabeshima Improvement of memory impairment by (+)- and (-)-pentazocine via kappa opioid and/or sigma receptors in mice Neurosci. Abstr. 30 2000 2015
18. J. Itoh, M. Ukai, and T. Kameyama Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice Eur. J. Pharmacol. 236 1993 341 345
19. M. King, Y.-X. Pan, J. Mei, A. Chang, J. Xu, and G.W. Pasternak Enhanced κ-opioid receptor-mediated analgesia by antisense targeting the σ 1 receptor Eur. J. Pharmacol. 331 1997 R5 R6
20. R. Leslie, and D. Jones Antisense gene knockdown in the nervous system revisited: optimism for the future Trends Neurosci. 20 1997 321 322
21. W.R. Martin, C.G. Eades, J.A. Thompson, R.E. Huppler, and P.E. Gilbert The effect of morphine and morphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog J. Pharmacol. Exp. Ther. 197 1976 517 532
22. A.M. Mathieu-Kia, L.Q. Fan, M.J. Kreek, E.J. Simon, and J.M. Hiller Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients Brain Res. 893 2001 121 134
23. K. Matsuno, K. Matsunaga, and S. Mita Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)-N-allylnormetazocine as measured by brain microdialysis Brain Res. 575 1992 315 319
24. K. Matsuno, K. Matsunaga, T. Senda, and S. Mita Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex J. Pharmacol. Exp. Ther. 265 1993 851 859
25. K. Matsuno, T. Senda, T. Kobayashi, and S. Mita Involvement of σ1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats Brain Res. 690 1995 200 206
26. K. Matsuno, M. Nakazawa, K. Okamoto, Y. Kawashima, and S. Mita Binding properties of SA4503, a novel and selective σ1 receptor agonist Eur. J. Pharmacol. 306 1996 271 279
27. T. Maurice, M. Hiramatsu, J. Itoh, T. Kameyama, T. Hasegawa, and T. Nabeshima Behavioral evidence for a modulating role of sigma ligands in memory processes: I. Attenuation of dizocilpine (MK-801)-induced amnesia Brain Res. 647 1994 44 56
28. A. Newhouse Cholinergic drug studies in dementia and depression Adv. Exp. Med. Ther. 282 1990 65 76
29. 3H] NE-100 in guinea pig brain Life Sci. 57 1995 333 337
30. Y.X. Pan, J. Cheng, J. Xu, G. Rossi, E. Jacobson, J. Ryan-Moro, A.I. Brooks, G.E. Dean, K.M. Standifer, and G.W. Pasternak Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor Mol. Pharmacol. 47 1995 1180 1188
31. G.W. Pasternak Multiple morphine and enkephalin receptors and the relief of pain JAMA 259 1988 1362 1367
32. G.W. Pasternak Pharmacological mechanisms of opioid analgesia Clin. Neuropharmacol. 16 1993 1 18
33. K.R. Pasternak, and K.M. Standifer Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology Trends Pharmacol. Sci. 16 1995 344 350
34. K.R. Pasternak, G.C. Rossi, A. Zuckerman, and G.W. Pasternak Antisense mapping KOR-1: evidence for multiple kappa analgesic mechanisms Brain Res. 826 1999 289 292
35. R. Quirion, W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.-P. Su, S.W. Tam, and D.P. Taylor A proposal for the classification of sigma binding sites Trends Pharmacol. Sci. 13 1992 85 86
36. M. Sarter, G. Bodewitz, and D.N. Stephens Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist β-carbolines Psychopharmacology 94 1988 491 495
37. A. Siniscalchi, P. Cristofori, and E. Veratti Influence of N-allyl-normetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 336 1987 425 429
38. B. Weiss, G. Davidkova, and S.-P. Zhang Antisense strategies in neurobiology Neurochem. Int. 31 1997 321 348